Texas Republicans propose changes to abortion bans after preventable deaths.
A New York clerk blocked a Texas court filing targeting a doctor who provided abortion pills.
A blood test may soon predict postpartum depression before symptoms arise.
RFK Jr. plans to cut 10,000 jobs, causing concerns over public health.
The 19th highlights how removing “DEI” efforts puts research on women’s health at risk.
A University of Oklahoma study found that waiting more than 42 days for certain breast cancer surgeries increased mortality risk.
Marty Makary faces controversies as the new FDA commissioner.
A review on how abortion rates increased after Roe v. Wade was overturned.
A deep dive on the ethical implications of working with human embryos.
A study examines the long-term impact of pregnancy on various organs and markers.
The Trump administration has frozen federal family-planning grants, affecting groups like Planned Parenthood.
The Wall Street Journal examines why women in their 30s and 40s are opting for facelifts earlier than before.
A Stanford economist study found that women who sought menopause treatment made 10% less income four years later.
A case at the Supreme Court could hit the entire Medicaid program by making key parts of the law unenforceable.
Maternal deaths due to cardiovascular issues more than doubled in the US between 1999 and 2022, with Black women and people in Southern states facing increased risk.
A systematic review found laser treatments improve menopause symptoms but do not enhance tissue quality.
Research compares telehealth patients seeking abortion pills for future use to those seeking them for current pregnancies.
A prenatal test that detects fetal abnormalities has also been shown to identify cancer in pregnant women.
A study suggests women with urinary incontinence can opt for non-invasive assessments instead of bladder pressure tests.
Trump nominates Susan Monarez as the permanent CDC director after pulling the previous nominee.